1. Accreditation of human research protection program: An Indian perspective;Bairy;Perspect Clin Res,2012
2. PTI 2013 Protest against Novartis’ attempt to obtain patent for Glivec in India The Hindu Businessline 24 Feb
3. EP News Bureau 2013 New rules on compensation to make clinical trials in India ‘virtually impossible’: ISCR The Express Pharma
4. Gleevec loses Indian patent battle;Jayraman;Nat Biotechnol,2013
5. K. Kulkarni S. Mohanty 2013 Novartis loses landmark India patent case on Glivec Reuters